AndreaBozzo/ceres-open-data-index huggingface dataset:
Hypothermia and neurologic outcome in patients following cardiac arrest: should we be hot to cool off our patients?

Hypothermia as a protectant of neurologic function in the treatment of cardiac arrest patients, although not a new concept, is now supported by two recent randomized, prospective clinical trials. The basic science research in support of the effects of hypothermia at the cellular and animal levels is extensive. The process of cooling for cerebral protection holds potential promise for human resuscitation efforts in multiple realms. It appears that, at least, those patients who suffer a witnessed cardiac arrest with ventricular fibrillation and early restoration of spontaneous circulation, such as those who were included in the European and Australian trials (discussed here), should be considered for hypothermic therapy.
4.18b Types of client payments accepted by facility, by facility operation and primary focus of facility: 2011. Percent

This is a National Survey of Substance Abuse Treatment Services (N-SSATS) data table showing types of client payments accepted by facility, by facility operation and primary focus of facility in 2011. N-SSATS is designed to collect data on the location, characteristics, and use of alcohol and drug abuse treatment facilities and services throughout the 50 States, the District of Columbia, and other U.S. jurisdictions.
Patent AT-E399928-T1: [Translated] METHOD FOR DEVELOPING A HYDROCARBON RESERVE AND SYSTEM COMPLEX FOR EXECUTING THE METHOD

The invention relates to oil and natural gas production and can be used for recovering hydrocarbons from hydrocarbon-bearing formations, for example, from oil-bearing formations, or, for example, from gas-condensate reservoirs. A method for recovery of hydrocarbons from a hydrocarbon-bearing formation, comprises: recovering a hydrocarbon-containing fluid through at least one production well, separating at least a part of a gaseous mixture from the fluid, injecting a gas through injection well. The separated gaseous mixture (all or a part of it) is combusted with air, which is used as oxidant, in a power plant, and, exhaust gases resulting from said combustion, which comprise nitrogen and carbon dioxide, are discharged from the power plant. Said air and the separated gaseous mixture are mixed and a gas-air mixture resulting from said mixing is compressed prior to said combustion, or the gas-air mixture is ignited during said compression. In the alternative embodiment of the invented method said air and the separated gaseous mixture are compressed and then are mixed to produce the gas-air mixture prior to said combustion, or the gas-air mixture is ignited, as soon as it is mixed. In both embodiments of the invented method the exhaust gases are compressed and used as an injection gas.
Nitric oxide: a pro-inflammatory mediator in lung disease?

Inflammatory diseases of the respiratory tract are commonly associated with elevated production of nitric oxide (NO•) and increased indices of NO• -dependent oxidative stress. Although NO• is known to have anti-microbial, anti-inflammatory and anti-oxidant properties, various lines of evidence support the contribution of NO• to lung injury in several disease models. On the basis of biochemical evidence, it is often presumed that such NO• -dependent oxidations are due to the formation of the oxidant peroxynitrite, although alternative mechanisms involving the phagocyte-derived heme proteins myeloperoxidase and eosinophil peroxidase might be operative during conditions of inflammation. Because of the overwhelming literature on NO• generation and activities in the respiratory tract, it would be beyond the scope of this commentary to review this area comprehensively. Instead, it focuses on recent evidence and concepts of the presumed contribution of NO• to inflammatory diseases of the lung.
Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of

Background
          Chlamydia pneumoniae infection has been detected by serological methods, but PCR is gaining more interest. A number of different PCR assays have been developed and some are used in combination with serology for diagnosis. Real-time PCR could be an attractive new PCR method; therefore it must be evaluated and compared to conventional PCR methods.
        
        
          Results
          We compared the performance of a newly developed real-time PCR with a conventional PCR method for detection of C. pneumoniae. The PCR methods were tested on reference samples containing C. pneumoniae DNA and on 136 nasopharyngeal samples from patients with a chronic cough. We found the same detection limit for the two methods and that clinical performance was equal for the real-time PCR and for the conventional PCR method, although only three samples tested positive. To investigate whether the low prevalence of C. pneumoniae among patients with a chronic cough was caused by suboptimal PCR efficiency in the samples, PCR efficiency was determined based on the real-time PCR. Seventeen of twenty randomly selected clinical samples had a similar PCR efficiency to samples containing pure genomic C. pneumoniae DNA.
        
        
          Conclusions
          These results indicate that the performance of real-time PCR is comparable to that of conventional PCR, but that needs to be confirmed further. Real-time PCR can be used to investigate the PCR efficiency which gives a rough estimate of how well the real-time PCR assay works in a specific sample type. Suboptimal PCR efficiency of PCR is not a likely explanation for the low positivity rate of C. pneumoniae in patients with a chronic cough.
COVID-19 Reported Patient Impact and Hospital Capacity by State

<p><b>After May 3, 2024, this dataset and webpage will no longer be updated because hospitals are no longer required to report data on COVID-19 hospital admissions, and hospital capacity and occupancy data, to HHS through CDC’s National Healthcare Safety Network. Data voluntarily reported to NHSN after May 1, 2024, will be available starting May 10, 2024, at <a href="https://covid.cdc.gov/covid-data-tracker/#hospitalizations-landing">COVID Data Tracker Hospitalizations</a>.</b></p>

<p>The following dataset provides state-aggregated data for hospital utilization. These are derived from reports with facility-level granularity across three main sources: (1) National Healthcare Safety Network (NHSN) (after December 15, 2022) (2) HHS TeleTracking (before December 15, 2022), (3) reporting provided directly to HHS Protect by state/territorial health departments on behalf of their healthcare facilities, and (4) historical NHSN timeseries data (before July 15, 2020). Data in this file have undergone routine data quality review of key variables of interest by subject matter experts to identify and correct obvious data entry errors. </p>

<p>The file will be updated regularly and provides the latest values reported by each facility within the last four days for all time. This allows for a more comprehensive picture of the hospital utilization within a state by ensuring a hospital is represented, even if they miss a single day of reporting.</p>

No statistical analysis is applied to account for non-response and/or to account for missing data.
<br><br>
The below table displays one value for each field (i.e., column). Sometimes, reports for a given facility will be provided to more than one reporting source: HHS TeleTracking, NHSN, and HHS Protect. When this occurs, to ensure that there are not duplicate reports, prioritization is applied to the numbers for each facility.
<br><br>
This file contains data that have been corrected based on additional data quality checks applied to select data elements. The resulting dataset allows various data consumers to use for their analyses a high-quality dataset with consistent standards of data processing and cleaning applied. 
 <br>
<p>
The following fields in this dataset are derived from data elements included in these data quality checks: 

<li>inpatient_beds 
<li>inpatient_beds_used
<li>total_staffed_adult_icu_beds 
<li>adult_icu_bed_utilization
<li>adult_icu_bed_utilization_numerator 
<li>adult_icu_bed_utilization_denominator
<li>adult_icu_bed_covid_utilization_numerator 
<li>adult_icu_bed_covid_utilization_denominator
<li>adult_icu_bed_covid_utilization
<li>total_adult_patients_hospitalized_confirmed_covid
<li>total_pediatric_patients_hospitalized_confirmed_covid
</p>
Youth Mental Health Tables (Prevalence Estimates) - 2.1 to 2.14

These are the detailed tables pertaining to adult mental health from the 2010 National Survey on Drug Use and Health (NSDUH). These detailed tables present totals and prevalence estimates for youths include major depressive episode (MDE), treatment for depression (among youths with MDE), mental health service utilization, and measures related to the co-occurrence of mental disorders with substance use or with substance use disorders. Results are provided for age group, gender, race/ethnicity, education level, government assistance status, poverty level, geographic area, insurance status. Comparisons are made between 2010 and 2002 to 2009.
Patent AT-E39952-T1: [Translated] TEXTILE REINFORCEMENT FOR THE MANUFACTURE OF LAMINATES.

1. Textile reinforcement for manufacturing layered products, of the type constituted by a web of longitudinal yarns (1) bound together by weft yarns (2a, 2b) loosely woven with said longitudinal yarns (1), said binding weft yarns being constituted of heat-meltable yarns of which the thermobinding properties are revealed after weaving, characterized by the fact that the weaving is produced in such a way that the weft yarns are regrouped in spaced apart pairs, said binding weft yarns being very fine with respect to the longitudinal yarns.
How hyperglycemia promotes atherosclerosis: molecular mechanisms

Both type I and type II diabetes are powerful and independent risk factors for coronary artery disease (CAD), stroke, and peripheral arterial disease. Atherosclerosis accounts for virtually 80% of all deaths among diabetic patients. Prolonged exposure to hyperglycemia is now recognized a major factor in the pathogenesis of atherosclerosis in diabetes. Hyperglycemia induces a large number of alterations at the cellular level of vascular tissue that potentially accelerate the atherosclerotic process. Animal and human studies have elucidated three major mechanisms that encompass most of the pathological alterations observed in the diabetic vasculature: 1) Nonenzymatic glycosylation of proteins and lipids which can interfere with their normal function by disrupting molecular conformation, alter enzymatic activity, reduce degradative capacity, and interfere with receptor recognition. In addition, glycosylated proteins interact with a specific receptor present on all cells relevant to the atherosclerotic process, including monocyte-derived macrophages, endothelial cells, and smooth muscle cells. The interaction of glycosylated proteins with their receptor results in the induction of oxidative stress and proinflammatory responses 2) oxidative stress 3) protein kinase C (PKC) activation with subsequent alteration in growth factor expression. Importantly, these mechanisms may be interrelated. For example, hyperglycemia-induced oxidative stress promotes both the formation of advanced glycosylation end products and PKC activation.
Patent AT-E401780-T1: [Translated] METHOD AND DEVICE FOR IRRIGATION BY FLOODING

The system includes a plurality of flood plains. Each flood plain contains a plurality of plants and each plant is held in a pot. The flood plains are excavated at different elevations from an upper most elevation to a lower most elevation. The flood plains are sequentially flooded for a resident time period with a selected volume of water directed from a water source. As the flood plains are excavated to different elevations, gravity, and a series of flood gates, control the water flow from one flood plain to a next lower flood plain. Each flood plain has a top surface and an underlying bed comprising a soil and clay composition. The surface of each bed is contoured to adequately drain water from one flood plain to the next. This clay mixture firms the bed to adequately support vehicles and laborers to prevent depressions in the bed which may adversely affect water flow in and out of a flood plain. Each of the flood plains is lined with a water impermeable membrane. The flood plains are also contoured to effectively drain water from one flood plain to the next. A water reclamation system is connected to the irrigation system. Water drained from the flood plains is collected in a retention pond and pumped to a holding pond. The water in the holding pond or reservoir is used to flood the irrigation field.
Table 20. Illicit Drug Dependence in the Past Year among Persons Aged 12 or Older, by State and Substate Regions: Percentages, Annual Averages Based on 2008, 2009, and 2010 NSDUHs

This table presents the 2008 to 2010 National Survey on Drug Use and Health (NSDUH) estimates of past year illicit drug dependence by those aged 12 or older by State and substate regions.
Twisted fallopian tube in pregnancy: a case report

Background
          Isolated twisted fallopian tube is an uncommon event, isolated twisted fallopian tube in pregnancy is also very rare. The diagnosis is often difficult and established during the operation. The right fallopian tube is most common affected.
        
        
          Case presentation
          We report an uncommon twisted left fallopian tube in pregnancy. A 34-year-old G3P2 28 weeks pregnant woman presented with acute left lower abdominal pain. The clinical and ultrasonographic findings led to diagnosis of twisted left ovarian cyst. Emergency exploratory laparotomy was performed. A twisted left fallopian tube and paratubal cyst was noted and left salpingectomy was performed. The postoperative course was uneventful and the pregnancy continued until term without complication.
        
        
          Conclusions
          Although isolated twisted fallopian tube during pregnancy is very rare, it should be included in the differential diagnosis of acute abdomen in pregnancy. Early surgical intervention will decrease obstetric morbidity and may allow preservation of the fallopian tube.
Compound 525066: (10,13-dimethyl-6,7,8,9,11,12,14,15-octahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy-trimethylsilane

Chemical compound data from PubChem database. IUPAC Name: (10,13-dimethyl-6,7,8,9,11,12,14,15-octahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy-trimethylsilane. Molecular Formula: C22H34OSi. Molecular Weight: 342.6. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 530605: p-Anisic acid, 2-(1-adamantyl)ethyl ester

Chemical compound data from PubChem database. IUPAC Name: 2-(1-adamantyl)ethyl 4-methoxybenzoate. Molecular Formula: C20H26O3. Molecular Weight: 314.4. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
NSDUH 2020 Sample Design Report

Learn about the sample design used for the 2020 National Survey on Drug Use and Health (NSDUH). The report describes the five stages of sample selection, sample weighting and variance estimation procedures, and the impact of the coronavirus disease 2019 (COVID-19) pandemic on sampling.Chapters:Introduces the report, describes the target population, provides a general overview of the 2020 NSDUH sample design, and summarizes the impact of the COVID-19 pandemic on the 2020 NSDUH.Summarizes the 2014 through 2022 coordinated sample design.Discusses the first three stages of sample selection in greater detail.Discusses the fourth and fifth stages of sample selection.Describes sample weighting and variance estimation procedures for 2020.Describes the Clinical Validation Study that was conducted in 2020.
Patent AT-E401157-T1: [Translated] CUTTING TOOL WITH CUTTING INSERTS

A rectangular blade-type cutting tool having two edge-on cutting inserts mounted at one end of the blade in a staggered formation with their cutting edges partially overlapping. This type of cutting blade finds particular application in disc-type cutting tool assemblies used for cutting pipes. In such a cutting tool assembly the blade-type cutting tools in accordance with the present invention are equally peripherally distributed on an end face of the cutting tool assembly with the operative cutting edges of each of cutting blade inwardly directed and equally distanced with respect to the axis of rotation of the cutting tool assembly. With such a cutting tool assembly it is only necessary to cut the thickness of a pipe without the necessity of passing across its entire diameter allowing for quick and economical cutting of the pipe.
Compound 525432: 3,5,5-Trimethyl-4-thiaheptane

Chemical compound data from PubChem database. IUPAC Name: 2-butan-2-ylsulfanyl-2-methylbutane. Molecular Formula: C9H20S. Molecular Weight: 160.32. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E400670-T1: [Translated] DEVICE AND METHOD FOR COOLING TAPE-SHAPED SUBSTRATES

The invention relates to a device and a method for cooling strip substrates in vacuo, whereby a substrate (1) is run such as to wrap around a convex cooling surface, at least partly in a contact region (3) and a gap (10) is formed between the substrate (1) and the cooling surface in the contact region (3), whereby, in at least one first region (11) of the gap (10), a fluid is introduced through the cooling surface and said fluid is at least partly drained through the cooling surface from at least one second region (12; 13) of the gap (10).
Compound 527545: 1-Heptyl-2,5-dimethylpyrrole

Chemical compound data from PubChem database. IUPAC Name: 1-heptyl-2,5-dimethylpyrrole. Molecular Formula: C13H23N. Molecular Weight: 193.33. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 527303: 8a-methyl-4-methylidene-6-propan-2-yl-3,4a,5,6,7,8-hexahydro-2H-naphthalen-1-one

Chemical compound data from PubChem database. IUPAC Name: 8a-methyl-4-methylidene-6-propan-2-yl-3,4a,5,6,7,8-hexahydro-2H-naphthalen-1-one. Molecular Formula: C15H24O. Molecular Weight: 220.35. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 526702: Perfluoro-pentan ethioic acid S-ethyl ester

Chemical compound data from PubChem database. IUPAC Name: S-ethyl 2,2,3,3,4,4,5,5,5-nonafluoropentanethioate. Molecular Formula: C7H5F9OS. Molecular Weight: 308.17. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 528131: 3-Methyl-5-(2-methylbutyl)-2-phenoxypyrazine

Chemical compound data from PubChem database. IUPAC Name: 3-methyl-5-(2-methylbutyl)-2-phenoxypyrazine. Molecular Formula: C16H20N2O. Molecular Weight: 256.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Managed Care Institutional Provider Network Data: December 31, 2013

The primary purpose for the Provider Network Data System is to collect data needed to evaluate the provider networks including physicians, hospitals, labs, home health agencies, durable medical equipment providers, etc., for all types of Managed Care plans in New York State, including HIV Special Need Plans (SNP), Family Health Plus (FHP) Buy-In, Programs of All-Inclusive Care for the Elderly (PACE), and Non-PACE Managed Long-Term Care (MLTC) plans. This dataset reflects institutional provider data. Provider Network Data System information is self reported. For more information, go to http://www.health.ny.gov/health_care/managed_care/.
Oxybutynin chloride

Oxybutynin Chloride Extended Release is a prescription medication used to treat symptoms of overactive bladder, such as frequent urination, urgency, and incontinence. It comes as oral extended-release tablets in 5mg, 10mg, and 15mg strengths, manufactured by Rising Pharma Holdings, Inc. This generic version is distributed by A-S Medication Solutions. This information was generated using AI and is provided for informational and research purposes only.
Jejunum free flap in hypopharynx reconstruction: Case series

Background
          Surgical treatment of hypopharyngeal cancers with extension to the retrocricoid region generally requires a circumferential pharyngolaryngectomy followed by a reconstruction of the removed segment of the upper digestive tract. Historically, many techniques have been used in order to achieve a safe and functional reconstruction. Jejunum interposition is generally considered the best reconstructive technique.
        
        
          Methods
          This study examines the details of the surgical technique, the complications, the oncological and the functional results in a series of 29 consecutive patients submitted to circumferential pharyngoesophageal resection for advanced hypopharyngeal cancer followed by reconstruction with a free flap of jejunum.
        
        
          Results
          Three of the transplants failed because of venous thrombosis. The overall success rate was 90%. There were no general complications. A good swallowing has been preserved in all our patients. All our patients where a phonatory prosthesis was positioned (20/29) were able to achieve speech following speech therapy and all were satisfied with their own capacity to communicate.
        
        
          Conclusions
          The prognosis of hypopharyngeal tumours (18–40% at 5 years) remains poor, but jejunum autografts are being shown to be an excellent choice for the reconstruction of the cervical hypopharyngo-oesophagus offering the patient fast rehabilitation and a reasonable quality of survival. Our experience confirm that this kind of reconstruction is safe with a good results in improving oncologic controls and restoring a good quality of life.
Compound 530622: 5-Chlorovaleric acid, 2-methyloct-5-yn-4-yl ester

Chemical compound data from PubChem database. IUPAC Name: 2-methyloct-5-yn-4-yl 5-chloropentanoate. Molecular Formula: C14H23ClO2. Molecular Weight: 258.78. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2011 CMHS Uniform Reporting System (URS) Output Tables for District of Columbia

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2011. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.